Clinical Trial Update: A Psoriasis Plaque Test Trial With LP0113 Spray in Patients With Psoriasis Vulgaris (LP0113-1123) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for LP0113 spray in psoriasis vulgaris (LP0113-1123); the study status is COMPLETED.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psoriasis Vulgaris

Drugs mentioned

• LP0113 spray (LP0113)

Snippet

Sponsor: LEO Pharma | Conditions: Skin and Connective Tissue Diseases | Phase 2 | Status: COMPLETED